ResearcherXuzhou Medical CollegeActive in the last 2 years

Gang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3336-0913; OpenAlex author ID A5100367367. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Global disparities in the burden of pancreatic cancer (1990-2021): insights from the 2021 Global Burden of Disease study. Co-author DOI 10.1186/s12885-025-14110-2 ↗
LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer. First author DOI 10.1111/jcmm.16784 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Genhai Shen · 1 shared paper, 2025 · strength 0.30
- Paper Global disparities in the burden of pancreatic cancer (1990-2021): insights from the 2021 Global Burden of Disease stud… DOI 10.1186/s12885-025-14110-2 ↗
Wei Chiang Liu · 1 shared paper, 2025 · strength 0.30
- Paper Global disparities in the burden of pancreatic cancer (1990-2021): insights from the 2021 Global Burden of Disease stud… DOI 10.1186/s12885-025-14110-2 ↗
Cong Bi · 1 shared paper, 2021 · strength 0.28
- Paper LINC00472 suppressed by ZEB1 regulates the miR-23a-3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer. DOI 10.1111/jcmm.16784 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.